BIOMAT Database Logo BIOMAT Database Logo

[Drug therapy of ischemic heart disease in ambulatory practice]. 1974

H J Duck, and H Trenckmann, and H J Fleischmann, and A Neugebauer, and J Schauer

UI MeSH Term Description Entries
D006993 Hypnotics and Sedatives Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. Hypnotic,Sedative,Sedative and Hypnotic,Sedatives,Hypnotic Effect,Hypnotic Effects,Hypnotics,Sedative Effect,Sedative Effects,Sedatives and Hypnotics,Effect, Hypnotic,Effect, Sedative,Effects, Hypnotic,Effects, Sedative,Hypnotic and Sedative
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D009573 Nitrites Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M Nitrite
D010099 Oxyfedrine A drug used in the treatment of angina pectoris, heart failure, conduction defects, and myocardial infarction. It is a partial agonist at beta adrenergic receptors and acts as a coronary vasodilator and cardiotonic agent. Oxyphedrin,Ildamen,Myofedrin,Oxifedrine,Oxiphedrin
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic
D000553 Ambulatory Care Health care services provided to patients on an ambulatory basis, rather than by admission to a hospital or other health care facility. The services may be a part of a hospital, augmenting its inpatient services, or may be provided at a free-standing facility. Outpatient Care,Outpatient Health Services,Clinic Visits,Health Services, Outpatient,Outpatient Services,Services, Outpatient Health,Urgent Care,Care, Ambulatory,Care, Outpatient,Care, Urgent,Cares, Urgent,Clinic Visit,Health Service, Outpatient,Outpatient Health Service,Outpatient Service,Service, Outpatient,Service, Outpatient Health,Services, Outpatient,Urgent Cares,Visit, Clinic,Visits, Clinic
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D000787 Angina Pectoris The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION. Angor Pectoris,Stenocardia,Stenocardias

Related Publications

H J Duck, and H Trenckmann, and H J Fleischmann, and A Neugebauer, and J Schauer
[Pharmacotherapy of ischemic heart disease in ambulatory practice].
June 1997, Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti,
H J Duck, and H Trenckmann, and H J Fleischmann, and A Neugebauer, and J Schauer
[Exercise therapy in the ambulatory treatment of chronic ischemic heart disease].
January 1981, Kardiologiia,
H J Duck, and H Trenckmann, and H J Fleischmann, and A Neugebauer, and J Schauer
[Therapy of lower extremity ischemic disease in ambulatory field practice using infusions].
July 1970, Casopis lekaru ceskych,
H J Duck, and H Trenckmann, and H J Fleischmann, and A Neugebauer, and J Schauer
[Current drug therapy of chronic ischemic heart disease].
January 1986, Terapevticheskii arkhiv,
H J Duck, and H Trenckmann, and H J Fleischmann, and A Neugebauer, and J Schauer
Drug therapy for hypertension and ischemic heart disease.
January 1980, International anesthesiology clinics,
H J Duck, and H Trenckmann, and H J Fleischmann, and A Neugebauer, and J Schauer
Changing patterns in drug therapy for ischemic heart disease.
March 1985, Canadian Medical Association journal,
H J Duck, and H Trenckmann, and H J Fleischmann, and A Neugebauer, and J Schauer
[Certain methods of drug therapy of ischemic heart disease].
April 1975, Sovetskaia meditsina,
H J Duck, and H Trenckmann, and H J Fleischmann, and A Neugebauer, and J Schauer
[Principles of modern drug therapy of ischemic heart disease].
January 1977, Terapevticheskii arkhiv,
H J Duck, and H Trenckmann, and H J Fleischmann, and A Neugebauer, and J Schauer
[Practice guidelines for therapy of patients with ischemic heart disease].
March 2002, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
H J Duck, and H Trenckmann, and H J Fleischmann, and A Neugebauer, and J Schauer
[Effect of ambulatory hypertension therapy on the development of chronic ischemic heart disease].
August 1973, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
Copied contents to your clipboard!